Newman Dignan & Sheerar, Inc. reports 1.84% decrease in ownership of BRM / Bristol-Myers Squibb Company

Bristol-Myers Squibb Company

DE ˙ XTRA ˙ US1101221083

47,43 € ↓ -0,01 (-0,01%)

2026-06-04
DEL PRIS

Security	DE:BRM / Bristol-Myers Squibb Company
Institution	Newman Dignan & Sheerar, Inc.
Latest Disclosed Ownership	17,477 shares
Latest Disclosed Value	$ 1,059,963

On April 13, 2026 - Newman Dignan & Sheerar, Inc. filed a 13F-HR form disclosing ownership of 17,477 shares of Bristol-Myers Squibb Company (DE:BRM) valued at $916,144 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 22, 2026 disclosing 17,804 shares of Bristol-Myers Squibb Company. This represents a change in shares of -1.84% during the quarter. The current value of the position is $828,934 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel Premium Registration Required .

Disclosed Equity Positions (from 13F/NPORT Filings)

File Date	Effective Date	Form	Security	Class	ID	Reported Shares	ΔShares	ΔShares (%)	Reported Value (x1000)	ΔValue (%)	Alloc (%)
2026-04-13	2026-03-31	13F	Bristol Myers Squibb	COM	110122108	17,477	-327	-1.84	1,060	10.31	0.2231
2026-01-22	2025-12-31	13F	Bristol Myers Squibb	COM	110122108	17,804	393	2.26	960	22.29	0.2001
2025-10-09	2025-09-30	13F	Bristol Myers Squibb	COM	110122108	17,411	-597	-3.32	785	-5.76	0.1696
2025-07-18	2025-06-30	13F	Bristol Myers Squibb	COM	110122108	18,008	39	0.22	834	-23.93	0.1916
2025-05-14	2025-03-31	13F/A-1	Bristol Myers Squibb	COM	110122108	17,969	322	1.82	1,096	9.72	0.2991
2025-05-02	2025-03-31	13F	Bristol Myers Squibb	COM	110122108	17,647	0		998		0.2557
2025-01-30	2024-12-31	13F	Bristol Myers Squibb	COM	110122108	17,647	-524	-2.88	998	4.39	0.2557
2024-11-12	2024-09-30	13F	Bristol Myers Squibb	COM	110122108	18,171	913	5.29	956	33.52	0.2291
2024-07-15	2024-06-30	13F	Bristol Myers Squibb	COM	110122108	17,258	-3,137	-15.38	717	-35.26	0.1848
2024-04-29	2024-03-31	13F	Bristol Myers Squibb	COM	110122108	20,395	-723	-3.42	1,106	2.12	0.2957
2024-02-09	2023-12-31	13F	Bristol Myers Squibb	COM	110122108	21,118	730	3.58	1,084	-8.45	0.3272
2023-11-08	2023-09-30	13F	Bristol Myers Squibb	COM	110122108	20,388	-1,006	-4.70	1,183	-13.52	0.3883
2023-08-02	2023-06-30	13F	Bristol Myers Squibb	COM	110122108	21,394	3	0.01	1,368	-7.69	0.4223
2023-04-28	2023-03-31	13F	Bristol Myers Squibb	COM	110122108	21,391	103	0.48	1,483	-3.20	0.4759
2023-01-20	2022-12-31	13F	Bristol Myers Squibb	COM	110122108	21,288	432	2.07	1,532	3.24	0.5074
2022-10-18	2022-09-30	13F	Bristol Myers Squibb	COM	110122108	20,856	136	0.66	1,483	-7.02	0.2323
2022-08-03	2022-06-30	13F	Bristol Myers Squibb	COM	110122108	20,720	-359	-1.70	1,595	3.57	0.5442
2022-04-14	2022-03-31	13F	Bristol Myers Squibb	COM	110122108	21,079	-21	-0.10	1,540	17.02	0.2955
2022-01-18	2021-12-31	13F	Bristol Myers Squibb	COM	110122108	21,100	27	0.13	1,316	5.53	0.3989
2021-10-07	2021-09-30	13F	Bristol Myers Squibb	COM	110122108	21,073	0	0.00	1,247	-11.43	0.3603
2021-07-28	2021-06-30	13F	Bristol Myers Squibb	COM	110122108	21,073	1,132	5.68	1,408	11.83	0.4745
2021-05-05	2021-03-31	13F	Bristol Myers Squibb	COM	110122108	19,941	231	1.17	1,259	2.94	0.4565
2021-01-29	2020-12-31	13F	Bristol Myers Squibb	COM	110122108	19,710	150	0.77	1,223	3.73	0.1966
2020-10-14	2020-09-30	13F	Bristol Myers Squibb	COM	110122108	19,560	-602	-2.99	1,179	-0.67	0.4927
2020-08-06	2020-06-30	13F	Bristol Myers Squibb	COM	110122108	20,162	502	2.55	1,187	1.54	0.5124
2020-04-20	2020-03-31	13F	Bristol Myers Squibb	COM	110122108	19,660	-790	-3.86	1,169	-10.97	0.6120
2020-01-15	2019-12-31	13F	Bristol Myers Squibb	COM	110122108	20,450	-620	-2.94	1,313	22.94	0.1402
2019-10-21	2019-09-30	13F	Bristol Myers Squibb	COM	110122108	21,070	-4,048	-16.12	1,068	-6.23	0.5031
2019-07-31	2019-06-30	13F	Bristol Myers Squibb	COM	110122108	25,118	-530	-2.07	1,139	-6.94	0.0303
2019-04-09	2019-03-31	13F	Bristol Myers Squibb	COM	110122108	25,648	-1,456	-5.37	1,224	-13.13	0.4919
2019-01-23	2018-12-31	13F	Bristol Myers Squibb	COM	110122108	27,104	-167	-0.61	1,409	-17.22	0.1194
2018-10-25	2018-09-30	13F	Bristol Myers Squibb	COM	110122108	27,271	12	0.04	1,702	12.79	0.7450
2018-07-06	2018-06-30	13F	Bristol Myers Squibb	COM	110122108	27,259	-2,032	-6.94	1,509	-12.17	0.1008
2018-04-17	2018-03-31	13F	Bristol Myers Squibb	COM	110122108	29,291	-1,359	-4.43	1,718	-8.52	0.8677
2018-01-29	2017-12-31	13F	Bristol Myers Squibb	COM	110122108	30,650	-719	-2.29	1,878	-6.05	0.9396
2017-10-18	2017-09-30	13F	Bristol Myers Squibb	COM	110122108	31,369	-905	-2.80	1,999	11.18	1.0658
2017-08-08	2017-06-30	13F	Bristol Myers Squibb	COM	110122108	32,274	-209	-0.64	1,798	-89.82	0.9978
2017-04-10	2017-03-31	13F	Bristol Myers Squibb	COM	110122108	32,483	-1,053	-3.14	17,668	801.43	7.8258
2017-01-27	2016-12-31	13F	Bristol Myers Squibb	COM	110122108	33,536	33,536	0.00	1,960		1.1951
2016-10-27	2016-09-30	13F	Bristol Myers Squibb	COM	110122108	0	-35,046	-100.00	0	-100.00
2016-07-08	2016-06-30	13F	Bristol Myers Squibb	COM	110122108	35,046	-397	-1.12	2,578	13.87	1.6108
2016-04-11	2016-03-31	13F	Bristol Myers Squibb	Equities	110122108	35,443	-335	-0.94	2,264	-8.00	1.6471
2016-01-13	2015-12-31	13F	Bristol Myers Squibb	COM	110122108	35,778	569	1.62	2,461	18.09	1.7377
2015-10-23	2015-09-30	13F	Bristol Myers Squibb	COM	110122108	35,209	-636	-1.77	2,084	-12.62	1.3397
2015-07-15	2015-06-30	13F	Bristol Myers Squibb	COM	110122108	35,845	870	2.49	2,385	960.00	1.7175
2015-04-10	2015-03-31	13F	Bristol Myers Squibb	COM	110122108	34,975	34,975	0.00	225		0.1606
2015-01-28	2014-12-31	13F	Bristol Myers Squibb	COM	110122108	0	-35,663	-100.00	0	-100.00
2014-10-16	2014-09-30	13F	Bristol Myers Squibb	COM	110122108	35,663	-2,146	-5.68	1,825	-0.49	1.3709
2014-07-22	2014-06-30	13F	Bristol Myers Squibb	COM	110122108	37,809	-4,666	-10.99	1,834	-16.90	1.0442
2014-05-07	2014-03-31	13F	Bristol Myers Squibb	COM	110122108	42,475	-156	-0.37	2,207	-2.60	1.5706
2014-02-12	2013-12-31	13F	Bristol Myers Squibb	COM	110122108	42,631	-659	-1.52	2,266	13.13	0.1109
2013-10-24	2013-09-30	13F	Bristol Myers Squibb	COM	110122108	43,290	268	0.62	2,003	4.16	1.5568
2013-08-20	2013-06-30	13F	Bristol Myers Squibb	COM	110122108	43,022	43,022		1,923		0.1476

Legend

Shares: The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value: The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price: The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class: This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred

Allocation (%): The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation: The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%): The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis: The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss: This is the market value of the position as of the effective date minus the cost basis.